Literature DB >> 15994854

Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation.

Murali Chandra1, Matthew L Tschirgi, Jil C Tardiff.   

Abstract

How different mutations in cardiac troponin T (cTnT) lead to distinct secondary downstream cellular remodeling in familial hypertrophic cardiomyopathy (FHC) remains elusive. To explore the molecular basis for the distinct impact of different mutations in cTnT on cardiac myocytes, we studied mechanical activity of detergent-skinned muscle fiber bundles from different lines of transgenic (TG) mouse hearts that express wild-type cTnT (WTTG), R92W cTnT, R92L cTnT, and Delta-160 cTnT (deletion of amino acid 160). The amount of mutant cTnT is approximately 50% of the total myocellular cTnT in both R92W and R92L TG mouse hearts and approximately 35% in Delta-160 TG mouse hearts. Myofilament Ca2+ sensitivity was enhanced in all mutant cTnT TG cardiac muscle fibers. Compared with the WTTG fibers, Ca2+ sensitivity increased significantly at short sarcomere length (SL) of 1.9 microm (P < 0.001) in R92W TG fibers by 2.2-fold, in R92L by 2.0-fold, and in Delta-160 by 1.3-fold. At long SL of 2.3 microm, Ca2+ sensitivity increased significantly (P < 0.01) in a similar manner (R92W, 2.5-fold; R92L, 1.9-fold; Delta-160, 1.3-fold). Ca2+-activated maximal tension remained unaltered in all TG muscle fibers. However, tension-dependent ATP consumption increased significantly in Delta-160 TG muscle fibers at both short SL (23%, P < 0.005) and long SL (37%, P < 0.0001), suggesting a mutation-induced change in cross-bridge detachment rate constant. Chronic stresses on relative cellular ATP level in cardiac myocytes may cause a strain on energy-dependent Ca2+ homeostatic mechanisms. This may result in pathological remodeling that we observed in Delta-160 TG cardiac myocytes where the ratio of sarco(endo)plasmic reticulum Ca2+-ATPase 2/phospholamban decreased significantly. Our results suggest that different types of stresses imposed on cardiac myocytes would trigger distinct cellular signaling, which leads to remodeling that may be unique to some mutants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994854     DOI: 10.1152/ajpheart.00571.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  50 in total

1.  Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

Authors:  Briar R Ertz-Berger; Huamei He; Candice Dowell; Stephen M Factor; Todd E Haim; Sara Nunez; Steven D Schwartz; Joanne S Ingwall; Jil C Tardiff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

2.  HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.

Authors:  Rachel K Moore; Lauren Tal Grinspan; Jesus Jimenez; Pia J Guinto; Briar Ertz-Berger; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2013-02-19       Impact factor: 5.000

3.  L71F mutation in rat cardiac troponin T augments crossbridge recruitment and detachment dynamics against α-myosin heavy chain, but not against β-myosin heavy chain.

Authors:  Sherif M Reda; Sampath K Gollapudi; Murali Chandra
Journal:  J Muscle Res Cell Motil       Date:  2016-12-14       Impact factor: 2.698

4.  Functional consequence of mutation in rat cardiac troponin T is affected differently by myosin heavy chain isoforms.

Authors:  Matthew L Tschirgi; Indika Rajapakse; Murali Chandra
Journal:  J Physiol       Date:  2006-04-27       Impact factor: 5.182

5.  Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.

Authors:  Sarah J Lehman; Lauren Tal-Grinspan; Melissa L Lynn; Joshua Strom; Grace E Benitez; Mark E Anderson; Jil C Tardiff
Journal:  Circulation       Date:  2019-03-19       Impact factor: 29.690

6.  Atomic resolution probe for allostery in the regulatory thin filament.

Authors:  Michael R Williams; Sarah J Lehman; Jil C Tardiff; Steven D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

7.  Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy.

Authors:  Mark Luedde; Ulrich Flögel; Maike Knorr; Christina Grundt; Hans-Joerg Hippe; Benedikt Brors; Derk Frank; Uta Haselmann; Claude Antony; Mirko Voelkers; Juergen Schrader; Patrick Most; Bjoern Lemmer; Hugo A Katus; Norbert Frey
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

8.  Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?

Authors:  David Dweck; Nir Hus; James D Potter
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

9.  Liver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytes.

Authors:  Samantha M Behunin; Marissa A Lopez-Pier; Rachel M Mayfield; Christiane A Danilo; Yulia Lipovka; Camille Birch; Sarah Lehman; Jil C Tardiff; Carol C Gregorio; John P Konhilas
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

10.  Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform.

Authors:  Steven J Ford; Ranganath Mamidi; Jesus Jimenez; Jil C Tardiff; Murali Chandra
Journal:  J Mol Cell Cardiol       Date:  2012-08-04       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.